Golden Sun Health Technology Group Limited
GSUN
$2.23
-$0.11-4.70%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 145.38% | 145.38% | 5.14% | 5.14% | -27.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 145.38% | 145.38% | 5.14% | 5.14% | -27.15% |
| Cost of Revenue | 175.40% | 175.40% | -9.22% | -9.22% | -24.54% |
| Gross Profit | 32.34% | 32.34% | 31.59% | 31.59% | -35.59% |
| SG&A Expenses | -19.93% | -19.93% | -46.79% | -46.79% | -22.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.31% | 66.31% | -35.47% | -35.47% | -23.30% |
| Operating Income | 33.80% | 33.80% | 70.74% | 70.74% | 17.78% |
| Income Before Tax | -6.17% | -6.17% | 52.46% | 52.46% | 17.89% |
| Income Tax Expenses | -173.18% | -173.18% | -23.23% | -23.23% | 65.08% |
| Earnings from Continuing Operations | -2.70% | -2.70% | 51.01% | 51.01% | 15.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4,111.11% | 4,111.11% | 400.00% | 400.00% | -84.57% |
| Net Income | 7.79% | 7.79% | 52.13% | 52.13% | 14.54% |
| EBIT | 33.80% | 33.80% | 70.74% | 70.74% | 17.78% |
| EBITDA | 33.31% | 33.31% | 71.50% | 71.50% | 17.74% |
| EPS Basic | 11.17% | 11.17% | 55.26% | 55.26% | 28.95% |
| Normalized Basic EPS | 48.48% | 48.48% | 58.02% | 58.02% | 31.14% |
| EPS Diluted | 11.17% | 11.17% | 55.26% | 55.26% | 28.95% |
| Normalized Diluted EPS | 48.48% | 48.48% | 58.02% | 58.02% | 31.14% |
| Average Basic Shares Outstanding | 3.78% | 3.78% | 6.98% | 6.98% | 20.30% |
| Average Diluted Shares Outstanding | 3.78% | 3.78% | 6.98% | 6.98% | 20.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |